Aducanumab approved by FDA for treating Alzheimer’s
FDA has approved AduhelmTM under the trademark for the first time since 2003 for treating Alzheimer’s. The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to delay further decline from Alzheimer’s disease and is also the first…